These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 28969635)

  • 1. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
    Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
    J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
    Onzi GR; Ledur PF; Hainzenreder LD; Bertoni AP; Silva AO; Lenz G; Wink MR
    Cytotherapy; 2016 Jul; 18(7):828-37. PubMed ID: 27210718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations.
    Fraga JS; Silva NA; Lourenço AS; Gonçalves V; Neves NM; Reis RL; Rodrigues AJ; Manadas B; Sousa N; Salgado AJ
    Biochimie; 2013 Dec; 95(12):2297-303. PubMed ID: 23851197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropism of mesenchymal stem cell toward CD133
    Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
    Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.
    Oliveira AI; Anjo SI; Vieira de Castro J; Serra SC; Salgado AJ; Manadas B; Costa BM
    Cell Commun Signal; 2017 Oct; 15(1):37. PubMed ID: 28969644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation.
    Teixeira FG; Carvalho MM; Neves-Carvalho A; Panchalingam KM; Behie LA; Pinto L; Sousa N; Salgado AJ
    Stem Cell Rev Rep; 2015 Apr; 11(2):288-97. PubMed ID: 25420577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Conditioned Medium from Bone Marrow Cells on Human Umbilical Cord Perivascular Cells.
    Kajiyama S; Nagashima Y; Funatsu T; Suzuki T; Fukaya M; Matsushima Y; Nagano T; Davies JE; Gomi K
    Tissue Eng Part A; 2021 Mar; 27(5-6):382-389. PubMed ID: 32718226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis.
    Pires AO; Mendes-Pinheiro B; Teixeira FG; Anjo SI; Ribeiro-Samy S; Gomes ED; Serra SC; Silva NA; Manadas B; Sousa N; Salgado AJ
    Stem Cells Dev; 2016 Jul; 25(14):1073-83. PubMed ID: 27226274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3.
    Nascimento RP; Dos Santos BL; da Silva KC; Amaral da Silva VD; de Fátima Costa M; David JM; David JP; Moura-Neto V; Oliveira MDN; Ulrich H; de Faria Lopes GP; Costa SL
    J Cell Physiol; 2021 Jul; 236(7):5022-5035. PubMed ID: 33368262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation.
    Salgado AJ; Fraga JS; Mesquita AR; Neves NM; Reis RL; Sousa N
    Stem Cells Dev; 2010 Jul; 19(7):1067-74. PubMed ID: 19705968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
    Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
    Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.
    Akimoto K; Kimura K; Nagano M; Takano S; To'a Salazar G; Yamashita T; Ohneda O
    Stem Cells Dev; 2013 May; 22(9):1370-86. PubMed ID: 23231075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome.
    Pietrobono D; Giacomelli C; Marchetti L; Martini C; Trincavelli ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties.
    Ribot J; Caliaperoumal G; Paquet J; Boisson-Vidal C; Petite H; Anagnostou F
    J Cell Mol Med; 2017 Feb; 21(2):349-363. PubMed ID: 27641937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Secreted Molecules of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells on Acute Hepatic Failure Model.
    Lotfinia M; Kadivar M; Piryaei A; Pournasr B; Sardari S; Sodeifi N; Sayahpour FA; Baharvand H
    Stem Cells Dev; 2016 Dec; 25(24):1898-1908. PubMed ID: 27676103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma.
    Yang N; Yan T; Zhu H; Liang X; Leiss L; Sakariassen PØ; Skaftnesmo KO; Huang B; Costea DE; Enger PØ; Li X; Wang J
    J Transl Med; 2014 Oct; 12():278. PubMed ID: 25280402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations.
    Ribeiro CA; Fraga JS; Grãos M; Neves NM; Reis RL; Gimble JM; Sousa N; Salgado AJ
    Stem Cell Res Ther; 2012 May; 3(3):18. PubMed ID: 22551705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype.
    Stazi G; Taglieri L; Nicolai A; Romanelli A; Fioravanti R; Morrone S; Sabatino M; Ragno R; Taurone S; Nebbioso M; Carletti R; Artico M; Valente S; Scarpa S; Mai A
    Clin Epigenetics; 2019 Dec; 11(1):173. PubMed ID: 31791385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.